Annual FCF
-$4.34 M
+$15.04 M+77.59%
December 31, 2023
Summary
- As of February 8, 2025, FRTX annual free cash flow is -$4.34 million, with the most recent change of +$15.04 million (+77.59%) on December 31, 2023.
- During the last 3 years, FRTX annual FCF has risen by +$15.71 million (+78.35%).
- FRTX annual FCF is now -823.83% below its all-time high of $600.00 thousand, reached on December 1, 1992.
Performance
FRTX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$1.12 M
-$4.21 M-136.47%
December 31, 2023
Summary
- As of February 8, 2025, FRTX quarterly free cash flow is -$1.12 million, with the most recent change of -$4.21 million (-136.47%) on December 31, 2023.
- Over the past year, FRTX quarterly FCF has dropped by -$4.21 million (-136.47%).
- FRTX quarterly FCF is now -107.14% below its all-time high of $15.75 million, reached on September 1, 2011.
Performance
FRTX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$4.34 M
+$1.45 M+25.08%
December 31, 2023
Summary
- As of February 8, 2025, FRTX TTM free cash flow is -$4.34 million, with the most recent change of +$1.45 million (+25.08%) on December 31, 2023.
- Over the past year, FRTX TTM FCF has increased by +$1.45 million (+25.08%).
- FRTX TTM FCF is now -225.59% below its all-time high of $3.46 million, reached on June 1, 2012.
Performance
FRTX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
FRTX Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +77.6% | -136.5% | +25.1% |
| 3 y3 years | +78.3% | -136.5% | +25.1% |
| 5 y5 years | +70.0% | -136.5% | +25.1% |
FRTX Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +88.0% | -136.5% | +88.2% | at high | +89.1% |
| 5 y | 5-year | at high | +88.0% | -136.5% | +92.2% | at high | +89.1% |
| alltime | all time | -823.8% | +88.0% | -107.1% | +94.1% | -225.6% | +89.1% |
Fresh Tracks Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | -$4.34 M(-77.6%) | -$1.12 M(-136.5%) | -$4.34 M(-25.1%) |
| Sep 2023 | - | $3.08 M(-269.7%) | -$5.80 M(-56.0%) |
| Jun 2023 | - | -$1.82 M(-59.5%) | -$13.17 M(-8.0%) |
| Mar 2023 | - | -$4.49 M(+74.0%) | -$14.33 M(-26.1%) |
| Dec 2022 | -$19.38 M(-46.4%) | -$2.58 M(-40.0%) | -$19.38 M(-10.3%) |
| Sep 2022 | - | -$4.29 M(+44.7%) | -$21.60 M(-24.1%) |
| Jun 2022 | - | -$2.97 M(-68.9%) | -$28.45 M(-28.5%) |
| Mar 2022 | - | -$9.54 M(+98.8%) | -$39.79 M(+10.0%) |
| Dec 2021 | -$36.18 M(+80.4%) | - | - |
| Dec 2021 | - | -$4.80 M(-56.9%) | -$36.18 M(+0.1%) |
| Sep 2021 | - | -$11.14 M(-22.1%) | -$36.14 M(+24.7%) |
| Jun 2021 | - | -$14.31 M(+141.3%) | -$28.98 M(+49.8%) |
| Mar 2021 | - | -$5.93 M(+24.8%) | -$19.36 M(-3.4%) |
| Dec 2020 | -$20.06 M(-44.3%) | -$4.75 M(+19.0%) | -$20.03 M(-31.7%) |
| Sep 2020 | - | -$3.99 M(-14.7%) | -$29.32 M(-22.4%) |
| Jun 2020 | - | -$4.68 M(-29.2%) | -$37.77 M(+1.3%) |
| Mar 2020 | - | -$6.61 M(-52.9%) | -$37.28 M(+3.6%) |
| Dec 2019 | -$35.99 M(+148.5%) | -$14.04 M(+12.9%) | -$35.99 M(+46.7%) |
| Sep 2019 | - | -$12.44 M(+196.9%) | -$24.53 M(+59.9%) |
| Jun 2019 | - | -$4.19 M(-21.2%) | -$15.34 M(+0.7%) |
| Mar 2019 | - | -$5.32 M(+106.2%) | -$15.23 M(+5.2%) |
| Dec 2018 | -$14.48 M(+66.8%) | -$2.58 M(-20.8%) | -$14.48 M(+6.1%) |
| Sep 2018 | - | -$3.26 M(-20.2%) | -$13.65 M(+2.4%) |
| Jun 2018 | - | -$4.08 M(-10.7%) | -$13.34 M(+16.5%) |
| Mar 2018 | - | -$4.57 M(+161.2%) | -$11.45 M(+31.9%) |
| Dec 2017 | -$8.68 M(+0.4%) | -$1.75 M(-40.5%) | -$8.68 M(-1.0%) |
| Sep 2017 | - | -$2.94 M(+34.1%) | -$8.77 M(-2.7%) |
| Jun 2017 | - | -$2.19 M(+21.8%) | -$9.01 M(+4.0%) |
| Mar 2017 | - | -$1.80 M(-1.9%) | -$8.66 M(+0.3%) |
| Dec 2016 | -$8.64 M(+22.2%) | -$1.83 M(-42.3%) | -$8.64 M(+0.0%) |
| Sep 2016 | - | -$3.18 M(+72.0%) | -$8.64 M(+62.1%) |
| Jun 2016 | - | -$1.85 M(+4.0%) | -$5.33 M(-10.4%) |
| Mar 2016 | - | -$1.78 M(-3.0%) | -$5.95 M(-15.9%) |
| Dec 2015 | -$7.07 M(-30.4%) | -$1.83 M(-1520.9%) | -$7.07 M(-10.9%) |
| Sep 2015 | - | $129.00 K(-105.2%) | -$7.94 M(-24.5%) |
| Jun 2015 | - | -$2.47 M(-15.0%) | -$10.51 M(-0.6%) |
| Mar 2015 | - | -$2.90 M(+7.4%) | -$10.57 M(+4.1%) |
| Dec 2014 | -$10.16 M(-66.7%) | -$2.70 M(+10.6%) | -$10.16 M(-21.6%) |
| Sep 2014 | - | -$2.44 M(-3.3%) | -$12.96 M(-32.9%) |
| Jun 2014 | - | -$2.53 M(+1.6%) | -$19.32 M(-21.1%) |
| Mar 2014 | - | -$2.49 M(-54.7%) | -$24.48 M(-19.8%) |
| Dec 2013 | -$30.54 M(+67.0%) | -$5.50 M(-37.6%) | -$30.54 M(-1.4%) |
| Sep 2013 | - | -$8.80 M(+14.4%) | -$30.97 M(+15.1%) |
| Jun 2013 | - | -$7.70 M(-9.9%) | -$26.91 M(+44.7%) |
| Mar 2013 | - | -$8.54 M(+44.3%) | -$18.59 M(+1.7%) |
| Dec 2012 | -$18.29 M(+325.1%) | -$5.92 M(+24.7%) | -$18.29 M(+7.3%) |
| Sep 2012 | - | -$4.75 M(-860.9%) | -$17.04 M(-592.7%) |
| Jun 2012 | - | $624.00 K(-107.6%) | $3.46 M(-194.7%) |
| Mar 2012 | - | -$8.24 M(+76.4%) | -$3.65 M(-15.1%) |
| Dec 2011 | -$4.30 M(-85.2%) | -$4.67 M(-129.7%) | -$4.30 M(-12.6%) |
| Sep 2011 | - | $15.75 M(-342.8%) | -$4.92 M(-81.7%) |
| Jun 2011 | - | -$6.49 M(-27.0%) | -$26.88 M(-3.8%) |
| Mar 2011 | - | -$8.89 M(+67.9%) | -$27.94 M(-3.6%) |
| Dec 2010 | -$28.99 M(+31.1%) | -$5.29 M(-14.7%) | -$28.99 M(-2.9%) |
| Sep 2010 | - | -$6.21 M(-17.8%) | -$29.84 M(+5.6%) |
| Jun 2010 | - | -$7.55 M(-24.0%) | -$28.25 M(+15.4%) |
| Mar 2010 | - | -$9.94 M(+61.6%) | -$24.48 M(+10.7%) |
| Dec 2009 | -$22.10 M(-30.8%) | -$6.15 M(+33.0%) | -$22.10 M(-2.0%) |
| Sep 2009 | - | -$4.62 M(+22.4%) | -$22.56 M(-13.8%) |
| Jun 2009 | - | -$3.78 M(-50.1%) | -$26.18 M(-9.2%) |
| Mar 2009 | - | -$7.56 M(+14.6%) | -$28.82 M(-9.7%) |
| Dec 2008 | -$31.92 M | -$6.60 M(-19.9%) | -$31.92 M(+5.5%) |
| Sep 2008 | - | -$8.24 M(+28.3%) | -$30.25 M(+14.5%) |
| Jun 2008 | - | -$6.42 M(-39.7%) | -$26.41 M(-4.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2008 | - | -$10.66 M(+116.1%) | -$27.70 M(+6.7%) |
| Dec 2007 | -$25.96 M(+50.7%) | -$4.93 M(+12.1%) | -$25.96 M(-6.1%) |
| Sep 2007 | - | -$4.40 M(-43.0%) | -$27.65 M(+23.7%) |
| Jun 2007 | - | -$7.71 M(-13.6%) | -$22.36 M(+23.2%) |
| Mar 2007 | - | -$8.92 M(+34.9%) | -$18.15 M(+5.3%) |
| Dec 2006 | -$17.23 M(-29.8%) | -$6.62 M(-840.0%) | -$17.23 M(+5.5%) |
| Sep 2006 | - | $894.00 K(-125.5%) | -$16.34 M(-29.5%) |
| Jun 2006 | - | -$3.50 M(-56.3%) | -$23.17 M(+7.0%) |
| Mar 2006 | - | -$8.01 M(+40.0%) | -$21.66 M(-11.8%) |
| Dec 2005 | -$24.55 M(-19.5%) | -$5.72 M(-3.7%) | -$24.55 M(-16.0%) |
| Sep 2005 | - | -$5.94 M(+198.6%) | -$29.24 M(-1.8%) |
| Jun 2005 | - | -$1.99 M(-81.7%) | -$29.77 M(-9.6%) |
| Mar 2005 | - | -$10.90 M(+4.7%) | -$32.92 M(+8.0%) |
| Dec 2004 | -$30.49 M(-15.3%) | -$10.41 M(+60.8%) | -$30.49 M(-22.4%) |
| Sep 2004 | - | -$6.47 M(+26.0%) | -$39.28 M(+3.9%) |
| Jun 2004 | - | -$5.14 M(-39.4%) | -$37.79 M(+7.2%) |
| Mar 2004 | - | -$8.47 M(-55.9%) | -$35.27 M(-2.0%) |
| Dec 2003 | -$36.00 M(+78.0%) | -$19.19 M(+285.2%) | -$36.00 M(+58.9%) |
| Sep 2003 | - | -$4.98 M(+90.5%) | -$22.65 M(+1.4%) |
| Jun 2003 | - | -$2.62 M(-71.6%) | -$22.34 M(-6.3%) |
| Mar 2003 | - | -$9.20 M(+57.2%) | -$23.84 M(+17.9%) |
| Dec 2002 | -$20.22 M(+97.3%) | -$5.85 M(+25.3%) | -$20.22 M(+13.4%) |
| Sep 2002 | - | -$4.67 M(+13.4%) | -$17.83 M(+23.8%) |
| Jun 2002 | - | -$4.12 M(-26.2%) | -$14.39 M(+20.9%) |
| Mar 2002 | - | -$5.58 M(+61.2%) | -$11.90 M(+16.2%) |
| Dec 2001 | -$10.25 M(+3.1%) | -$3.46 M(+179.8%) | -$10.25 M(+8.1%) |
| Sep 2001 | - | -$1.24 M(-24.0%) | -$9.47 M(-1.0%) |
| Jun 2001 | - | -$1.63 M(-58.5%) | -$9.57 M(-6.2%) |
| Mar 2001 | - | -$3.92 M(+45.8%) | -$10.20 M(+2.7%) |
| Dec 2000 | -$9.93 M(+55.2%) | -$2.69 M(+102.2%) | -$9.93 M(+20.5%) |
| Sep 2000 | - | -$1.33 M(-41.2%) | -$8.24 M(-12.4%) |
| Jun 2000 | - | -$2.26 M(-38.2%) | -$9.42 M(+5.1%) |
| Mar 2000 | - | -$3.66 M(+265.5%) | -$8.96 M(+39.9%) |
| Dec 1999 | -$6.40 M(+18.5%) | -$1.00 M(-60.0%) | -$6.40 M(+8.5%) |
| Sep 1999 | - | -$2.50 M(+38.9%) | -$5.90 M(-3.3%) |
| Jun 1999 | - | -$1.80 M(+63.6%) | -$6.10 M(0.0%) |
| Mar 1999 | - | -$1.10 M(+120.0%) | -$6.10 M(+13.0%) |
| Dec 1998 | -$5.40 M(+8.0%) | -$500.00 K(-81.5%) | -$5.40 M(-1.8%) |
| Sep 1998 | - | -$2.70 M(+50.0%) | -$5.50 M(+103.7%) |
| Jun 1998 | - | -$1.80 M(+350.0%) | -$2.70 M(+8.0%) |
| Mar 1998 | - | -$400.00 K(-33.3%) | -$2.50 M(-50.0%) |
| Dec 1997 | -$5.00 M(-15.3%) | -$600.00 K(-700.0%) | -$5.00 M(-21.9%) |
| Sep 1997 | - | $100.00 K(-106.3%) | -$6.40 M(-22.0%) |
| Jun 1997 | - | -$1.60 M(-44.8%) | -$8.20 M(+24.2%) |
| Mar 1997 | - | -$2.90 M(+45.0%) | -$6.60 M(+11.9%) |
| Dec 1996 | -$5.90 M(+59.5%) | -$2.00 M(+17.6%) | -$5.90 M(+40.5%) |
| Sep 1996 | - | -$1.70 M(<-9900.0%) | -$4.20 M(-2.3%) |
| Jun 1996 | - | $0.00(-100.0%) | -$4.30 M(+16.2%) |
| Mar 1996 | - | -$2.20 M(+633.3%) | -$3.70 M(0.0%) |
| Dec 1995 | -$3.70 M(-14.0%) | -$300.00 K(-83.3%) | -$3.70 M(-14.0%) |
| Sep 1995 | - | -$1.80 M(-400.0%) | -$4.30 M(+13.2%) |
| Jun 1995 | - | $600.00 K(-127.3%) | -$3.80 M(-19.1%) |
| Mar 1995 | - | -$2.20 M(+144.4%) | -$4.70 M(+9.3%) |
| Dec 1994 | -$4.30 M(+126.3%) | -$900.00 K(-30.8%) | -$4.30 M(0.0%) |
| Sep 1994 | - | -$1.30 M(+333.3%) | -$4.30 M(-6.5%) |
| Jun 1994 | - | -$300.00 K(-83.3%) | -$4.60 M(+12.2%) |
| Mar 1994 | - | -$1.80 M(+100.0%) | -$4.10 M(+115.8%) |
| Dec 1993 | -$1.90 M(-416.7%) | -$900.00 K(-43.8%) | -$1.90 M(+90.0%) |
| Sep 1993 | - | -$1.60 M(-900.0%) | -$1.00 M(-266.7%) |
| Jun 1993 | - | $200.00 K(-50.0%) | $600.00 K(+50.0%) |
| Mar 1993 | - | $400.00 K | $400.00 K |
| Dec 1992 | $600.00 K(-142.9%) | - | - |
| Dec 1991 | -$1.40 M(-6.7%) | - | - |
| Dec 1990 | -$1.50 M | - | - |
FAQ
- What is Fresh Tracks Therapeutics annual free cash flow?
- What is the all time high annual FCF for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics annual FCF year-on-year change?
- What is Fresh Tracks Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics quarterly FCF year-on-year change?
- What is Fresh Tracks Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Fresh Tracks Therapeutics?
- What is Fresh Tracks Therapeutics TTM FCF year-on-year change?
What is Fresh Tracks Therapeutics annual free cash flow?
The current annual FCF of FRTX is -$4.34 M
What is the all time high annual FCF for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high annual free cash flow is $600.00 K
What is Fresh Tracks Therapeutics annual FCF year-on-year change?
Over the past year, FRTX annual free cash flow has changed by +$15.04 M (+77.59%)
What is Fresh Tracks Therapeutics quarterly free cash flow?
The current quarterly FCF of FRTX is -$1.12 M
What is the all time high quarterly FCF for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high quarterly free cash flow is $15.75 M
What is Fresh Tracks Therapeutics quarterly FCF year-on-year change?
Over the past year, FRTX quarterly free cash flow has changed by -$4.21 M (-136.47%)
What is Fresh Tracks Therapeutics TTM free cash flow?
The current TTM FCF of FRTX is -$4.34 M
What is the all time high TTM FCF for Fresh Tracks Therapeutics?
Fresh Tracks Therapeutics all-time high TTM free cash flow is $3.46 M
What is Fresh Tracks Therapeutics TTM FCF year-on-year change?
Over the past year, FRTX TTM free cash flow has changed by +$1.45 M (+25.08%)